Deprodone
Alternative Names: EclarLatest Information Update: 24 Oct 2021
Price :
$50 *
At a glance
- Originator Abbott GmbH & Co. KG
- Developer SSP Co
- Class Anti-inflammatories; Antipsoriatics; Corticosteroids; Small molecules
- Mechanism of Action Arachidonic acid inhibitors; Immunosuppressants; Lipocortin synthesis agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Skin disorders
Most Recent Events
- 13 Mar 2001 BASF's pharmaceutical business has been acquired by Abbott Laboratories
- 02 Dec 1999 SS Pharmaceuticals is now called SSP Co
- 05 Jan 1996 Launched for Skin disorders in Japan (Topical)